Gold standard monitoring of HCC in patients with cirrhosis is cost-effective

(Wiley) Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. A new analysis indicates that following screening guidelines for HCC in cirrhotic patients is lifesaving and cost-effective compared with 'real life' monitoring.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news